Lys147

Site Information
rLAADVGkGAAQREF SwissProt Entrez-Gene
Blast this site against: NCBI SwissProt PDB
Site Group ID: 8113924
Available spectra: 2 CST

In vivo Characterization
Methods used to characterize site in vivo:	mass spectrometry ( 1 , 2 , 3 , 4 , 5 , 6 )
Disease tissue studied:	gastric cancer ( 5 ) , leukemia ( 1 ) , chronic myelogenous leukemia ( 1 ) , liver cancer ( 1 ) , lung cancer ( 2 , 3 , 4 ) , non-small cell lung cancer ( 2 , 4 , 6 ) , non-small cell lung adenocarcinoma ( 2 , 3 , 4 ) , non-small cell squamous cell lung carcinoma ( 3 )
Relevant cell line - cell type - tissue:	A549 (pulmonary) ( 2 ) , Cal-12T (pulmonary) ( 4 ) , HCC15 (pulmonary) ( 3 ) , HCC44 (pulmonary) ( 4 ) , K562 (erythroid) ( 1 ) , liver ( 1 ) , LOU-NH91 (squamous) ( 3 ) , lung ( 2 , 3 , 4 ) , MKN-45 (gastric) ( 5 ) , NCI-H1355 (pulmonary) ( 2 ) , NCI-H1437 (pulmonary) ( 4 ) , NCI-H1666 (pulmonary) ( 4 ) , NCI-H1703 (squamous) ( 3 ) , NCI-H1792 (pulmonary) ( 2 ) , NCI-H2073 (pulmonary) ( 3 ) , NCI-H23 (pulmonary) ( 2 ) , NCI-H2342 (pulmonary) ( 3 ) , NCI-H2405 (pulmonary) ( 4 ) , NCI-H3255 (pulmonary) ( 6 ) , NCI-H441 (pulmonary) ( 2 )

References
1	Wu Z, et al. (2015) A chemical proteomics approach for global analysis of lysine monomethylome profiling. Mol Cell Proteomics 14, 329-39 25505155 Curated Info
2	Rikova K (2013) CST Curation Set: 20127; Year: 2013; Biosample/Treatment: cell line, A549, H1355, H23, H441, H1792; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1K Curated Info
3	Rikova K (2013) CST Curation Set: 20130; Year: 2013; Biosample/Treatment: cell line, H2342, H2073, Lou-NH91, HCC15, H1703; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1K Curated Info
4	Rikova K (2013) CST Curation Set: 20132; Year: 2013; Biosample/Treatment: cell line, H1666, CAL-12T, H2405, HCC44, H1437; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1K Curated Info
5	Rikova K (2012) CST Curation Set: 16501; Year: 2012; Biosample/Treatment: cell line, MKN45/crizotinib; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1K Curated Info
6	Rikova K (2012) CST Curation Set: 16502; Year: 2012; Biosample/Treatment: cell line, H3255/iressa; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1K Curated Info